A Gene-Expression Signature as a Predictor of Survival in Breast CancerMarc J. van de Vijver, René Bernards, Yudong D. He et al.|New England Journal of Medicine|2002Cited by 6.5k
Impact of a Higher Radiation Dose on Local Control and Survival in Breast-Conserving Therapy of Early Breast Cancer: 10-Year Results of the Randomized Boost Versus No Boost EORTC 22881-10882 TrialHarry Bartelink, Laurence Collette, M. Piérart et al.|Journal of Clinical Oncology|2007Cited by 1k
Internal Mammary and Medial Supraclavicular Irradiation in Breast CancerPhilip Poortmans, Walter Van den Bogaert, Sandra Collette et al.|New England Journal of Medicine|2015Cited by 1k
Recurrence Rates after Treatment of Breast Cancer with Standard Radiotherapy with or without Additional RadiationHarry Bartelink, M. Piérart, Jean-Claude Horiot et al.|New England Journal of Medicine|2001Cited by 950
Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trialHarry Bartelink, Laurence Collette, P. Maingon et al.|The Lancet Oncology|2014Cited by 679